@article{ART002843711},
author={Mehnaz and Yasmeen Shamsi and Md. Wasi Akhtar and Sahar Zaidi and Sujata Mohanty and Sayeed Ahmad},
title={An overview of Acne Vulgaris (Busoor Labaniya)},
journal={CELLMED},
issn={3022-6805},
year={2022},
volume={12},
number={2},
pages={9-9},
doi={10.5667/CellMed.2022.009}
TY - JOUR
AU - Mehnaz
AU - Yasmeen Shamsi
AU - Md. Wasi Akhtar
AU - Sahar Zaidi
AU - Sujata Mohanty
AU - Sayeed Ahmad
TI - An overview of Acne Vulgaris (Busoor Labaniya)
JO - CELLMED
PY - 2022
VL - 12
IS - 2
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 9
EP - 9
SN - 3022-6805
AB - Acne vulgaris is a common dermatological condition affecting the pilosebaceous units and having a multifactorial etiology. In Unani terminology, acne vulgaris is referred as Busoor Labaniya, characterized by white lesions on the face, nose, and cheeks; on squeezing, release cheesy material. In conventional medicine, mild cases are best addressed with topical regimens, but more severe cases require systemic medications. Retinoids (retinoic acid, adapalene, isotretinoin, tazarotene), benzoyl peroxide, clindamycin, erythromycin, and azelaic acid are a few examples of topical medications, whereas systemic drugs include antibiotics (Doxycycline, minocycline, erythromycin, azithromycin). In the Unani System of Medicine, numerous single and compound drugs have been used to treat Busoor Labaniya. These drugs are considered harmless and do not have any major side effects. In Unani system of medicine, acne vulgaris is effectively managed with natural medicines as well as therapeutic regimens with minimal side effects even after long-term usage. Acne vulgaris is usually treated with systemic blood purifiers along with topical Unani drugs. Hence, clinical studies with proper scientific parameters are needed to be conducted to establish and validate their efficacy in the prevention and control of acne vulgaris.
KW - Busoor Labaniya;Comedones;Pilosebaceous unit;Propionibacterium acnes
DO - 10.5667/CellMed.2022.009
ER -
Mehnaz, Yasmeen Shamsi, Md. Wasi Akhtar, Sahar Zaidi, Sujata Mohanty and Sayeed Ahmad. (2022). An overview of Acne Vulgaris (Busoor Labaniya). CELLMED, 12(2), 9-9.
Mehnaz, Yasmeen Shamsi, Md. Wasi Akhtar, Sahar Zaidi, Sujata Mohanty and Sayeed Ahmad. 2022, "An overview of Acne Vulgaris (Busoor Labaniya)", CELLMED, vol.12, no.2 pp.9-9. Available from: doi:10.5667/CellMed.2022.009
Mehnaz, Yasmeen Shamsi, Md. Wasi Akhtar, Sahar Zaidi, Sujata Mohanty, Sayeed Ahmad "An overview of Acne Vulgaris (Busoor Labaniya)" CELLMED 12.2 pp.9-9 (2022) : 9.
Mehnaz, Yasmeen Shamsi, Md. Wasi Akhtar, Sahar Zaidi, Sujata Mohanty, Sayeed Ahmad. An overview of Acne Vulgaris (Busoor Labaniya). 2022; 12(2), 9-9. Available from: doi:10.5667/CellMed.2022.009
Mehnaz, Yasmeen Shamsi, Md. Wasi Akhtar, Sahar Zaidi, Sujata Mohanty and Sayeed Ahmad. "An overview of Acne Vulgaris (Busoor Labaniya)" CELLMED 12, no.2 (2022) : 9-9.doi: 10.5667/CellMed.2022.009
Mehnaz; Yasmeen Shamsi; Md. Wasi Akhtar; Sahar Zaidi; Sujata Mohanty; Sayeed Ahmad. An overview of Acne Vulgaris (Busoor Labaniya). CELLMED, 12(2), 9-9. doi: 10.5667/CellMed.2022.009
Mehnaz; Yasmeen Shamsi; Md. Wasi Akhtar; Sahar Zaidi; Sujata Mohanty; Sayeed Ahmad. An overview of Acne Vulgaris (Busoor Labaniya). CELLMED. 2022; 12(2) 9-9. doi: 10.5667/CellMed.2022.009
Mehnaz, Yasmeen Shamsi, Md. Wasi Akhtar, Sahar Zaidi, Sujata Mohanty, Sayeed Ahmad. An overview of Acne Vulgaris (Busoor Labaniya). 2022; 12(2), 9-9. Available from: doi:10.5667/CellMed.2022.009
Mehnaz, Yasmeen Shamsi, Md. Wasi Akhtar, Sahar Zaidi, Sujata Mohanty and Sayeed Ahmad. "An overview of Acne Vulgaris (Busoor Labaniya)" CELLMED 12, no.2 (2022) : 9-9.doi: 10.5667/CellMed.2022.009
